Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

XB130, a new adaptor protein, regulates expression of tumor suppressive microRNAs in cancer cells.

Takeshita H, Shiozaki A, Bai XH, Iitaka D, Kim H, Yang BB, Keshavjee S, Liu M.

PLoS One. 2013;8(3):e59057. doi: 10.1371/journal.pone.0059057. Epub 2013 Mar 19.

2.

XB130, a novel adaptor protein, promotes thyroid tumor growth.

Shiozaki A, Lodyga M, Bai XH, Nadesalingam J, Oyaizu T, Winer D, Asa SL, Keshavjee S, Liu M.

Am J Pathol. 2011 Jan;178(1):391-401. doi: 10.1016/j.ajpath.2010.11.024. Epub 2010 Dec 23.

3.

Ionizing radiation-inducible microRNA miR-193a-3p induces apoptosis by directly targeting Mcl-1.

Kwon JE, Kim BY, Kwak SY, Bae IH, Han YH.

Apoptosis. 2013 Jul;18(7):896-909. doi: 10.1007/s10495-013-0841-7.

PMID:
23546867
4.

Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.

Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M.

Urol Oncol. 2012 Jul-Aug;30(4):434-43. doi: 10.1016/j.urolonc.2010.05.008. Epub 2010 Sep 16.

PMID:
20843712
5.

[Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].

Fu XY, Tan DM, Hou ZH, Hu ZL, Liu GZ, Ouyang Y, Liu F.

Zhonghua Gan Zang Bing Za Zhi. 2012 Aug;20(8):598-604. doi: 10.3760/cma.j.issn.1007-3418.2012.08.012. Chinese.

PMID:
23207154
6.

Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.

Nakano H, Yamada Y, Miyazawa T, Yoshida T.

Int J Oncol. 2013 Jun;42(6):1875-82. doi: 10.3892/ijo.2013.1896. Epub 2013 Apr 15.

7.

Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.

Rivas MA, Venturutti L, Huang YW, Schillaci R, Huang TH, Elizalde PV.

Breast Cancer Res. 2012 May 14;14(3):R77.

8.

Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.

Yu X, Zhang X, Dhakal IB, Beggs M, Kadlubar S, Luo D.

BMC Cancer. 2012 Jan 20;12:29. doi: 10.1186/1471-2407-12-29.

9.

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.

Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J.

Cancer Res. 2008 Apr 1;68(7):2094-105. doi: 10.1158/0008-5472.CAN-07-5194.

10.

The proto-oncogene Pim-1 is a target of miR-33a.

Thomas M, Lange-Grünweller K, Weirauch U, Gutsch D, Aigner A, Grünweller A, Hartmann RK.

Oncogene. 2012 Feb 16;31(7):918-28. doi: 10.1038/onc.2011.278. Epub 2011 Jul 11.

PMID:
21743487
11.

MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.

Zheng C, Yinghao S, Li J.

Med Oncol. 2012 Jun;29(2):815-22. doi: 10.1007/s12032-011-9934-8. Epub 2011 Apr 13.

PMID:
21487968
12.

Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.

Buechner J, Tømte E, Haug BH, Henriksen JR, Løkke C, Flægstad T, Einvik C.

Br J Cancer. 2011 Jul 12;105(2):296-303. doi: 10.1038/bjc.2011.220. Epub 2011 Jun 7.

13.

Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.

Isozaki Y, Hoshino I, Nohata N, Kinoshita T, Akutsu Y, Hanari N, Mori M, Yoneyama Y, Akanuma N, Takeshita N, Maruyama T, Seki N, Nishino N, Yoshida M, Matsubara H.

Int J Oncol. 2012 Sep;41(3):985-94. doi: 10.3892/ijo.2012.1537. Epub 2012 Jun 28.

PMID:
22752059
14.

miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST.

Zhou Y, Huang Z, Wu S, Zang X, Liu M, Shi J.

J Exp Clin Cancer Res. 2014 Jan 27;33:12. doi: 10.1186/1756-9966-33-12.

15.

c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.

Kawano M, Tanaka K, Itonaga I, Iwasaki T, Tsumura H.

PLoS One. 2015 Sep 22;10(9):e0138560. doi: 10.1371/journal.pone.0138560. eCollection 2015.

16.

MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2.

Shang C, Lu YM, Meng LR.

Med Sci Monit. 2012 Apr;18(4):BR149-55.

17.

MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion.

Xu N, Zhang L, Meisgen F, Harada M, Heilborn J, Homey B, Grandér D, Ståhle M, Sonkoly E, Pivarcsi A.

J Biol Chem. 2012 Aug 24;287(35):29899-908. doi: 10.1074/jbc.M112.391243. Epub 2012 Jul 10.

18.

Identification of a set of miRNAs differentially expressed in transiently TIA-depleted HeLa cells by genome-wide profiling.

Sánchez-Jiménez C, Carrascoso I, Barrero J, Izquierdo JM.

BMC Mol Biol. 2013 Feb 6;14:4. doi: 10.1186/1471-2199-14-4.

19.

Optimization of a microRNA expression vector for function analysis of microRNA.

Furukawa N, Sakurai F, Katayama K, Seki N, Kawabata K, Mizuguchi H.

J Control Release. 2011 Feb 28;150(1):94-101. doi: 10.1016/j.jconrel.2010.12.001. Epub 2010 Dec 10.

PMID:
21146569
20.

Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.

Takakura S, Mitsutake N, Nakashima M, Namba H, Saenko VA, Rogounovitch TI, Nakazawa Y, Hayashi T, Ohtsuru A, Yamashita S.

Cancer Sci. 2008 Jun;99(6):1147-54. doi: 10.1111/j.1349-7006.2008.00800.x. Epub 2008 Apr 21.

Items per page

Supplemental Content

Write to the Help Desk